PPI plus aspirin improves outcomes in Barrett's esophagus

The combination of aspirin and a high-dose proton-pump inhibitor (PPI) improves outcomes in patients with Barrett’s esophagus, according to results of the The Aspirin and Esomeprazole Chemoprevention in Barrett’s metaplasia Trial (AspECT)
https://www.mdlinx.com/gastroenterology/top-medical-news/article/2018/08/03/7540353/

AUDIENCES

Caregivers
Friends and Family
General Public
Medical Profession
Patients
Survivors

SUBJECTS

Post Surgical

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino